Helena J Teede and colleagues’ global consensus to rename polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS) is an important advance.1 The previous term is ...

Many women with polycystic ovary syndrome don’t have ovarian cysts, despite what its name suggests. Now renamed polyendocrine metabolic ovarian syndrome (PMOS), the condition is increasingly ...

Cyst link debunked: A Finnish population study found women with PCOS do not have higher rates of abnormal ovarian cysts than those without the condition. Heart risk revealed: A Nordic study of over ...

Dr Lucy Joslin, GP and women’s health lead at Healthcare Group, explains more about the misunderstood condition that affects ...

Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). Professor Helena Teede led this name change after 14 years of research and global collaboration. But ...

More women could now receive an earlier diagnosis following the renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine ...

A hormonal disorder affecting about 1 in 8 women worldwide has officially been renamed after years of concern that its old name pointed patients, doctors, and researchers in the wrong direction.

In a major shift aimed at ending years of confusion and missed diagnoses, the condition commonly known as Polycystic Ovarian Syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome ...

PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition ...